Klaria Pharma Holding AB (KLAR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.706x

Based on the latest financial reports, Klaria Pharma Holding AB (KLAR) has a cash flow conversion efficiency ratio of 0.706x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.74 Million ≈ $-294.65K USD) by net assets (Skr-3.88 Million ≈ $-417.44K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Klaria Pharma Holding AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Klaria Pharma Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read KLAR current and long-term liabilities for a breakdown of total debt and financial obligations.

Klaria Pharma Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Klaria Pharma Holding AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Alla Public Company Limited BK:ALLA	0.049x
Femasys Inc NASDAQ:FEMY	-0.713x
Hua Yang Bhd KLSE:5062	-0.100x
Peruvian Metals Corp V:PER	-0.001x
Renrenle Commercial Group Co Ltd SHE:002336	0.110x
Arctic Gold Publ AB ST:ARCT	-0.102x
Guardian Exploration Inc V:GX	0.634x
HiTi Digital Inc TW:3494	-0.084x

Annual Cash Flow Conversion Efficiency for Klaria Pharma Holding AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Klaria Pharma Holding AB from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Klaria Pharma Holding AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-3.88 Million ≈ $-417.44K	Skr-35.04 Million ≈ $-3.77 Million	9.032x	+350.12%
2024-12-31	Skr3.31 Million ≈ $355.67K	Skr-11.94 Million ≈ $-1.28 Million	-3.611x	-1539.91%
2023-12-31	Skr41.13 Million ≈ $4.43 Million	Skr-9.06 Million ≈ $-974.79K	-0.220x	+66.31%
2022-12-31	Skr76.08 Million ≈ $8.19 Million	Skr-49.73 Million ≈ $-5.35 Million	-0.654x	-82.97%
2021-12-31	Skr69.42 Million ≈ $7.47 Million	Skr-24.80 Million ≈ $-2.67 Million	-0.357x	-10.92%
2020-12-31	Skr109.59 Million ≈ $11.79 Million	Skr-35.30 Million ≈ $-3.80 Million	-0.322x	-78.73%
2019-12-31	Skr82.11 Million ≈ $8.84 Million	Skr-14.80 Million ≈ $-1.59 Million	-0.180x	-86.99%
2018-12-31	Skr94.70 Million ≈ $10.19 Million	Skr-9.13 Million ≈ $-982.10K	-0.096x	-22.67%
2017-12-31	Skr153.52 Million ≈ $16.52 Million	Skr-12.06 Million ≈ $-1.30 Million	-0.079x	+12.65%
2016-12-31	Skr160.04 Million ≈ $17.22 Million	Skr-14.39 Million ≈ $-1.55 Million	-0.090x	-254.52%
2015-12-31	Skr174.59 Million ≈ $18.79 Million	Skr-4.43 Million ≈ $-476.63K	-0.025x	--

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$23.19 Million

Skr215.48 Million SEK

Market Cap Rank

#24562 Global

#486 in Sweden

Share Price

Skr0.88

Change (1 day)

-1.13%

52-Week Range

Skr0.40 - Skr1.22

All Time High

Skr17.00